Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Charges of employment discrimination dismissed by the District Court of Pirkanmaa

Alma Media Corporation                                 Press release 5 December 2019 CHARGES OF EMPLOYMENT DISCRIMINATION DISMISSED BY THE DISTRICT COURT OF PIRKANMAA The District Court of Pirkanmaa has today, 5 December 2019, issued its ruling in the case of suspected employment discrimination in the recruitment of Aamulehti’s Editor-in-Chief in late 2017. The District Court of Pirkanmaa has dismissed the charges of employment discrimination against Alma Media Corporation’s President and CEO Kai Telanne and SVP, Human Resources Virpi Juvonen. In its ruling, the District Court

Circular economy – a hot topic for the European Union

Today, the Swedish Foundation for Strategic Environmental Research, Stockholm Environment Institute and the Institute for European Environmental Policy are proud to announce a policy dialogue on solutions for advancing the European circular economy through the European Green Deal, that will be unveiled on 11 December.A report from the European Environment Agency recently identified textiles as the fourth largest cause of environmental pressure on primary raw materials and water from EU consumption (after food, housing and transport). How might the environmental footprint of imported

Data to be highlighted at the American Society of Hematology 2019 Annual Meeting

Sobi™ and its wholly owned subsidiary Dova Pharmaceuticals, will present new data from studies with avatrombopag for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) as well as patients with chronic immune thrombocytopenia (ITP) at the 61st Annual Meeting of the American Society of Hematology (ASH) taking place in Orlando, 7-10 December. In addition, final data from the phase 1/2 repeat dose study with BIVV001 (rFVIIIFc-VWF-XTEN) in severe haemophilia A will be highlighted in a presentation as well as the adaptive design of a study evaluating emapalumab

First patient dosed in landmark Menstrual Migraine study

Asarina Pharma AB (publ) (ASAP: FN Stockholm) has administered the first dose in its Phase IIa trial of a new, preventative treatment for menstrual migraine. Sepranolone is the first woman-only migraine treatment, specifically targeting menstrual migraine.Globally, three times more women than men suffer from migraine. Approximately 50 million of those also suffer from menstrual migraine, a more severe form highly resistant to standard treatments, including recently developed CGRP antibodies. Sepranolone is the first compound to target this highly frequent form of female migraine. If

Fortum-Rusnano wind investment fund to start implementation of 50-MW project in Russia

FORTUM CORPORATION INVESTOR NEWS 5 DECEMBER 2019 13.30 EET The Fortum-Rusnano wind investment fund has taken the investment decision for a 50-megawatt (MW) wind power project in the Rostov region, Russia. It is the fifth project of the total 1,823 MW awarded to the fund in the Russian wind auction in 2017 and 2018. The wind farm is expected to start production during the fourth quarter of 2020. In the Rostov region, the partnership is already constructing 300 MW of wind power. Power production and capacity supply is expected to start during the first half of 2020. The first joint

Zwipe announced rights issue and published prospectus

On 4 December 2019 Zwipe AS announced its approved and published prospectus regarding rights issue.  Reference is made to the announcement made by Zwipe AS (the Company) on 10 November 2019 of the preferential rights issue of up to NOK 74.5 million by issuing up to 10,635,525 new shares in the Company, and the announcement of the approval by the extraordinary general meeting in the Company of the preferential rights issue on 2 December 2019.The prospectus containing complete information regarding the rights issue and information about the Company was approved by the Financial

Refinancing update, summons to bondholders' meetings in DOF Subsea AS

DOF ASA AND DOF Subsea AS: REFINANCING UPDATE, SUMMONS TO BONDHOLDERS’ MEETINGS IN DOF SUBSEA AS As previously reported in DOF Subsea AS’ (“DOF Subsea” or the “Company”) financial report for Q2 and Q3 2019, the DOF Subsea Group (the “Group”) experience that regular financing and refinancing has been challenging. The Group has an order backlog of approximately NOK 14 billion per 30 September 2019. The market has improved slightly, and the Company has a higher EBITDA compared to last year. However, the current EBITDA is still not sufficient to cover the Group's current amortisation

RaySearch will expand to new headquarters in 2021

RaySearch Laboratories AB (publ) has experienced strong growth in recent years, creating the need for larger and more efficient premises. During the third quarter of 2021, the medical technology company will move its headquarters from Sveavägen 44 to a new location in Hagastaden in Stockholm, which is expected to become one of the world's leading life science hubs.Karin Gedda, architect and interior designer, Strategisk Arkitektur, says: "RaySearch is an innovative and high-performing software company that needs a work environment that strengthens and motivates its employees. Therefore, we

Sign up soon: entries for the Better with Less – Design Challenge 2019–2020 close on 5 January

Metsä Board Corporation press release 05.12.2019The closing date for the second Better with Less – Design Challenge is approaching, with last entries to be submitted by 5 January 2020. The competition – organised by Metsä Board, the leading European producer of premium fresh fibre paperboards and part of Metsä Group – encourages designers and design students to come up with innovative packaging solutions that will have a positive impact on sustainability. Submissions are being received in four categories – cosmetics, e-commerce, food packaging and a ‘wild card’ category, with cash prizes

Video presentation (ENG) of clinical status of RP101 by CEO Martin Vidaeus

CEO Martin Vidaeus of Redwood Pharma updates industry and shareholders of the status of the RP101 Phase II trial at the Bio-Stock forum on December 3, 2019 in Stockholm, Sweden. About RP101RP101 is a novel, topical treatment for post-menopausal women suffering from chronic, moderate-to-severe dry eye disease (DED), and consists of a low-dose estrogen analog formulated in a proprietary controlled-release drug delivery platform, IntelliGel. The active substance has already been proven safe and efficacious in two Phase II clinical trials conducted in the US. Redwood Pharma is currently

SBB included in well-renowned property index

EPRA (European Public Real Estate Association) has today published its quarterly index review of the FTSE EPRA Nareit Global Real Estate Index, in which Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB ") has been included. The index series is seen as the leading benchmark for listed property investments. “To be included in the FTSE EPRA Nareit Global Real Estate Index has been a goal for SBB and it is therefore gratifying that we have now been included. It reflects our ambition to be the largest social infrastructure property owner in the Nordics”, says Ilija Batljan, CEO and Founder of

Cantargia selects CAN10 as development project in systemic sclerosis and myocarditis

Cantargia AB today announced that its research platform CANxx has progressed with the start of a drug development project, CAN10. The project originates from inhibition of three inflammatory cytokine systems (IL-1, IL-33 and IL-36) by antibody targeting of interleukin 1 receptor accessory protein (IL1RAP). The project will focus on unmet medical need in systemic sclerosis and myocarditis. The goal is to initiate clinical development late 2021.Cantargia develops antibody-based pharmaceuticals against the interleukin 1 receptor accessory protein (IL1RAP). The lead project CAN04 is in phase

Vestas strengthens its Executive Management with newly appointed EVP of People and Culture and appoints new interim EVP of Manufacturing & Global Procurement

News release from Vestas Wind Systems A/SAarhus, 5 December 2019 By the turn of the year, a new addition will be made to Vestas’ Executive Management team with the appointment of Kerstin Knapp as Executive Vice President of People & Culture, thereby emphasising the importance of the employees as the company’s strongest asset. At the same time, another change will take place in Executive Management, as Jean-Marc Lechêne has announced his retirement and Tommy Rahbek Nielsen will step in as interim EVP of Manufacturing & Global Procurement.In a rapidly maturing and changing wind energy

Caverion wins a building technology project for the Berlin University of Medicine in Germany

Caverion Corporation Investor news 5 December at 11.15 a.m. EETCaverion wins a building technology project for the Berlin University of Medicine in Germany A former operation theatre building at the Charité, Berlin University of Medicine in Germany will be converted into a modern research building which will be used as an outpatient and translational research and innovation centre. For the project, Caverion will implement the technical installations related to Automation, Cooling, Security and Safety, Ventilation and Air Conditioning, Heating and Sanitation, and Electricity. The Charité

Alimak Group closes one assembly plant in China for wind tower internals

Following the changed market conditions for wind tower internals during 2019, Alimak Group today announces the decision to close down Avanti’s assembly plant in Tianjin, China.During 2019, Alimak Group’s tower internals business under the Avanti brand has faced aggressive price competition, primarily in China. This has had a negative impact on the Group’s business unit Wind, part of the Industrial Equipment business area though the service lift and ladder parts of the Wind business has continued to perform well. As communicated in Alimak Group’s Q3 report, published on October 23, 2019,

Midroc New Technology returns as owner in PowerCell following share acquisition from Finindus

PowerCell Sweden AB has been informed that the formerly large shareholder in PowerCell, Midroc New Technology, has acquired 2,138,114 shares in PowerCell, representing 4.1 percent of votes and capital, from the Belgian investment company Finindus. The transaction means that Midroc New Technology returns as a large owner in PowerCell and that Finindus decreases its ownership in PowerCell from 8.0 percent to 3.9 percent.Midroc New Technology is a venture capital company within Midroc Europe, an international company group headquartered in Stockholm. Midroc New Technology has been an owner in

Lehto will build a datacenter for Yandex in Mäntsälä

Lehto Group PlcPress release5 December 2019 at 10.30 AMLehto Tilat Oy and Yandex, an IT corporation that runs Russia’s largest web search engine, have agreed on the construction of a datacenter in Mäntsälä. This project will measure about 10,000 m2 of gross floor area. Construction will begin in December and it is expected to be completed in autumn 2020. “From the beginning, we particularly noticed the commitment of Lehto’s representatives and their authentic desire to start implementing this project in cooperation with us and listening to our wishes. Lehto is truly driven to learn

Teleste to deliver on-board solution to Stadler’s EMUs in Stockholm, Sweden

TURKU, FINLAND – 5 December 2019 – Teleste Corporation will deliver an on-board solution to Stadler’s electrical multiple units (EMU) for Public Transport Administration Stockholm in Sweden. With deliveries starting in 2019, the deployment will consist of an on-board solution for 22 EMUs and the agreement also includes an option for another 45 EMUs. “We are looking forward to working with Stadler in providing Public Transport Administration Stockholm with an on-board solution that is designed for today’s effective and attractive public transport. We are confident that our reliable and

Teleste to deliver on-board solution to Stadler’s EMUs in Stockholm, Sweden

TELESTE CORPORATION   INVESTOR NEWS   5.12.2019   AT 10:15 EET TELESTE TO DELIVER ON-BOARD SOLUTION TO STADLER'S EMUS IN STOCKHOLM, SWEDEN Teleste will deliver an on-board solution to Stadler's electrical multiple units (EMU) for Public Transport Administration Stockholm in Sweden. With deliveries starting in 2019, the deployment will consist of an on-board solution for 22 EMUs and the agreement also includes an option for another 45 EMUs. The EMUs will operate on the Roslagsbanan route connecting the northern and eastern regions of the Swedish capital. To increase responsiveness

Axfood presents logistics solution of the future at Capital Markets Day

Axfood is holding a Capital Markets Day today. The theme for the day is the company’s future logistics and the new, highly automated logistics centre outside Stockholm.The Capital Markets Day will be moderated by Klas Balkow, President and CEO of Axfood, with input also from CFO Anders Lexmon. The agenda includes presentations from Axfood’s purchasing and logistics company Dagab, which will be given by Nicholas Pettersson, President of Dagab, Per Gifvas, Programme Head for the new logistics centre, Raymond Lundmark, Head of Logistics, and Helena Blom, Transport Manager. In addition, the

Contract extension for CSV Normand Tonjer

Solstad Offshore ASA is pleased to announce that a client has exercised their option to extend the present contract for the CSV Normand Tonjer with 12 months to November 2020. In addition, the client has the option to extend the contract until September 2021. Solstad Offshore owns 56% of “Normand Tonjer”   Skudeneshavn, December 5th, 2019 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Anders Hall Jomaas CFO, at +47 40 04 29 18 Solstad Offshore ASAwww.solstad.com This information is subject of the disclosure requirements according to the Norwegian Securities

Astralis Group A/S: Completion of the offering and registration of share capital increase

Completion of the offering and registration of share capital increaseIn accordance with company announcement no. 1-2019 dated 14 November 2019 and no. 2-2019 dated 2 December 2019 regarding the offering of the shares (the “Offering”) in Astralis Group A/S (the “Company”), the share capital increase of 16,759,777 new shares of nominally DKK 0.01 each has as of the date of this announcement been registered with the Danish Business Authority. The offering has hereby been completed. Hereafter, the Company’s nominal share capital is 567,597.77 divided into 56,759,777 shares of nominally DKK 0.

Secret career app MeetFrank raises €1.5M to tear down international borders for global talent

MeetFrank launches new “relocation without location” feature for app to help global talent relocate and find new, fulfilling opportunities abroad.Tallinn, Estonia (December 5th, 2019) Secret career app startup MeetFrank  today announced its closure of a €1.5M funding round led by investors Karma.vc , Enern VC , Change Ventures , and Hummingbird . MeetFrank will use the capital to launch its new “relocation without location” feature that opens up international

Inwido's Finnish business units Sydänpuu, Profin and Klas1 appoints new Managing Directors

Three of Inwido's Finnish business units have appointed new MD´s. Aki Lindgrén has been appointed MD of Klas1 and Ville Nevala as acting MD of Profin. The third appointment concerns Sydänpuu, whose new MD is Markus Palola.In connection with Mikko Haapala leaving the MD assignments in Profin, Sydänpuu and Klas1, three internal recruitments are taking place for the MD posts. Both Aki Lindgren and Ville Nevala have solid sales and leadership experience from the business units they now take over the leadership in. In Sydänpuu, a subsidiary of Profin, Markus Palola is appointed MD. Markus Palola

There are no items matching the current filter
There are no more items matching the current filter
Back to top